Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | AURKA | O14965 | 2/20 | 0.33 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.33 |
| ▸ | LTB4R | Q15722 | 2/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TOP2A | P11388 | 1/20 | 0.31 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.31 |
| ▸ | PLAU | P00749 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6774778 | 0.88 | PTGS1 (0.44) | PTGS1PTGS2AURKAAURKBTBXAS1 | |
| SCHEMBL6074447 | 0.80 | PLK4 (0.43) | PTGS1PTGS2AURKAAURKBMEN1 | |
| SCHEMBL6074435 | 0.80 | PLK4 (0.43) | PTGS1PTGS2AURKAAURKBMEN1 | |
| Hydrochloric Acid SCHEMBL6074379 | 0.79 | PLK4 (0.42) | PTGS1PTGS2AURKAAURKBMEN1 | |
| Hydrochloric Acid SCHEMBL6074385 | 0.79 | PLK4 (0.42) | PTGS1PTGS2AURKAAURKBMEN1 | |
| Hydrochloric Acid SCHEMBL6074903 | 0.72 | MEN1 (0.50) | PTGS1PTGS2MEN1LMNAKMT2A | |
| SCHEMBL6074466 | 0.71 | PTGS1 (0.39) | PTGS1PTGS2MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL6074390 | 0.70 | PTGS1 (0.39) | PTGS1PTGS2MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL6743159 | 0.67 | KMT2A (0.50) | PTGS1PTGS2ALOX5MEN1LMNA | |
| Hydrochloric Acid SCHEMBL6074699 | 0.66 | PTGS1 (0.57) | PTGS1PTGS2TBXAS1ALOX5LTB4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6777557-B2 | Method and composition for rejuvenating cells, tissues organs, hair and nails | FARRINGTON PHARMACEUTICALS, LLC | 2004-08-17 | — | — | US | disclosed |
| US-20020188015-A1 | Method and composition for rejuvinating cells, tissues organs, hair and nails | FARRINGTON PHARMACEUTICALS, LLC | 2002-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020188015-A1 | Method and composition for rejuvinating cells, tissues organs, hair and nails | TERT, TELO2, HKDC1 | PTGS1 4108/4885PTGS2 4133/4885AURKA 2995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.